HYUGA PRIMARY CARE Co.,Ltd. (7133) AI Stock Analysis

Compare

0 Followers

Top Page

HYUGA PRIMARY CARE Co.,Ltd.

(7133)

Rating:78Outperform

Price Target:

¥1,761.00

▲(21.45%Upside)

HYUGA PRIMARY CARE Co.,Ltd. demonstrates strong financial performance and bullish technical indicators, contributing to a favorable stock outlook. The valuation is fair, supporting the overall positive assessment. The lack of earnings call and corporate events data does not detract from the company's strong position.

HYUGA PRIMARY CARE Co.,Ltd. (7133) vs. iShares MSCI Japan ETF (EWJ)

Market Cap

¥10.55B

Dividend Yield1.38%

Average Volume (3M)9.25K

Price to Earnings (P/E)14.3

Beta (1Y)0.46

Revenue Growth20.50%

EPS Growth62.52%

CountryJP

Employees544

SectorHealthcare

Sector Strength41

IndustryMedical - Care Facilities

Share Statistics

EPS (TTM)45.58

Shares Outstanding7,277,200

10 Day Avg. Volume12,800

30 Day Avg. Volume9,246

Financial Highlights & Ratios

PEG Ratio0.39

Price to Book (P/B)4.51

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

HYUGA PRIMARY CARE Co.,Ltd. Business Overview & Revenue Model

Company DescriptionHYUGA PRIMARY CARE Co., Ltd. operates in the healthcare sector, focusing on providing primary care services. The company is dedicated to delivering quality healthcare solutions through its network of clinics and healthcare facilities. Its core services include general medical consultations, preventive care, and health management tailored to meet the needs of its diverse patient base.

How the Company Makes MoneyHYUGA PRIMARY CARE Co., Ltd. generates revenue primarily through patient fees for medical consultations and various healthcare services offered at its clinics. The company may also earn income from partnerships with healthcare providers, insurance companies, or government healthcare programs, which can contribute to patient referrals and service reimbursements. Additionally, HYUGA PRIMARY CARE Co., Ltd. might engage in wellness programs or corporate health services, providing tailored health management solutions to businesses, further diversifying its revenue streams.

HYUGA PRIMARY CARE Co.,Ltd. Financial Statement Overview

Summary

HYUGA PRIMARY CARE Co.,Ltd. exhibits a strong financial performance with impressive revenue growth, profitability, and cash flow management. The balance sheet reflects disciplined leverage and equity management. Rising liabilities require attention, but the company's operational performance and cash generation capabilities position it well for future growth.

Income Statement

Very Positive

HYUGA PRIMARY CARE Co.,Ltd. has demonstrated strong revenue growth over recent years, with a notable increase from 4,331 million JPY in 2020 to 9,984 million JPY in 2025. The company has maintained healthy gross profit and net profit margins, indicating efficient cost management and profitability. The EBIT and EBITDA margins further highlight operational efficiency, contributing to a strong financial position.

Balance Sheet

Positive

The company's balance sheet reflects a solid equity base, with stockholders' equity increasing significantly over the years. The debt-to-equity ratio has been managed well, showing a stable leverage position. Return on equity has improved, indicating effective use of shareholder funds. However, the total liabilities have also increased, necessitating careful financial management to maintain stability.

Cash Flow

Very Positive

HYUGA PRIMARY CARE Co.,Ltd. has shown consistent growth in free cash flow, supported by strong operating cash flows. The operating cash flow to net income ratio is robust, indicating good cash generation relative to earnings. Despite fluctuations in capital expenditures, the company has managed to maintain positive free cash flow, supporting its operational and expansion activities.

TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Breakdown
Income Statement		Total Revenue
8.73B	9.98B	8.29B	6.66B	5.78B	5.09B
	Gross Profit
2.01B	2.41B	1.88B	1.56B	1.24B	783.83M
	EBIT
800.12M	1.05B	710.68M	530.30M	519.11M	228.20M
	EBITDA
884.71M	1.31B	854.38M	627.27M	587.61M	258.55M
	Net Income Common Stockholders
499.36M	719.03M	441.03M	382.88M	328.45M	97.14M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
668.26M	565.93M	688.01M	567.69M	719.56M	538.29M
	Total Assets
3.01B	7.05B	6.35B	2.91B	2.53B	2.02B
	Total Debt
328.22M	2.65B	2.80B	251.54M	330.21M	447.63M
	Net Debt
-340.04M	2.08B	2.11B	-316.15M	-389.34M	-90.66M
	Total Liabilities
1.65B	4.68B	4.71B	1.43B	1.46B	1.41B
	Stockholders Equity
1.36B	2.37B	1.64B	1.48B	1.07B	609.46M
Cash Flow		Free Cash Flow
0.00	485.51M	473.20M	102.59M	228.92M	277.22M
	Operating Cash Flow
0.00	771.32M	706.64M	342.25M	484.60M	351.82M
	Investing Cash Flow
0.00	-473.98M	-1.13B	-383.39M	-320.25M	-77.59M
	Financing Cash Flow
0.00	-419.43M	538.78M	-110.73M	16.93M	36.64M

HYUGA PRIMARY CARE Co.,Ltd. Technical Analysis

Technical Analysis Sentiment

Neutral

Last Price1450.00

Price Trends

50DMA

1366.02

Positive

100DMA

1337.25

Positive

200DMA

1286.48

Positive

Market Momentum

MACD

33.99

Positive

RSI

50.06

Neutral

STOCH

15.53

Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7133, the sentiment is Neutral. The current price of 1450 is below the 20-day moving average (MA) of 1489.20, above the 50-day MA of 1366.02, and above the 200-day MA of 1286.48, indicating a neutral trend. The MACD of 33.99 indicates Positive momentum. The RSI at 50.06 is Neutral, neither overbought nor oversold. The STOCH value of 15.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7133.

HYUGA PRIMARY CARE Co.,Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (54)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7133	78 Outperform	¥10.55B	14.34		1.38%	20.50%	62.52%
2425	74 Outperform	¥3.00B	8.02		2.53%	2.33%	-0.96%
2374	73 Outperform	¥19.50B	12.93		3.85%	4.15%	-25.66%
7129	71 Outperform	¥3.03B	9.51		2.77%	4.85%	4759.88%
7061	69 Neutral	¥10.19B	18.41		1.24%	21.97%	-20.94%
7091	64 Neutral	¥4.04B	10.94		―	15.25%	93.03%
Sector *	54 Neutral	$5.31B	3.26	-45.10%	2.79%	16.76%	0.02%

* Healthcare Sector Average

Performance Comparison

JP:7133

HYUGA PRIMARY CARE Co.,Ltd.

1,441.00

-231.96

-13.87%

JP:2374

Saint-Care Holding Corp.

760.00

-46.85

-5.81%

JP:2425

Care Service Co., Ltd.

796.00

-41.52

-4.96%

JP:7061

Japan Hospice Holdings Inc.

1,234.00

-269.49

-17.92%

JP:7091

Living Platform Ltd.

899.00

-257.00

-22.23%

JP:7129

Miahelsa Holdings Corporation

1,092.00

71.83

7.04%

Glossary

OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.

NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.

UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.